Ideaya Biosciences Inc
IDYA
Market Cap$1.83B
Close$
$-0.65
103.6% downside
Current Fair Value
103.6% downsideOvervalued by 103.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.83 Billion |
|---|---|
| Enterprise Value | $1.77 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-3.36 |
| Beta | 0.51 |
| Outstanding Shares | 87,340,758 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -6.66 |
|---|---|
| PEG | -7.5 |
| Price to Sales | - |
| Price to Book Ratio | 1.52 |
| Enterprise Value to Revenue | 450.41 |
| Enterprise Value to EBIT | -7.82 |
| Enterprise Value to Net Income | -10 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Ideaya Biosciences Inc
CEO: Yujiro Hata